pmc logo image
Therapeutic targets in systemic sclerosis
Christopher P Denton
Arthritis Res Ther. 2007; 9(Suppl 2): S6. Published online 2007 August 15. doi: 10.1186/ar2190
PMCID:
PMC2072882
Abstract Full Text PDF–525K
 Is Cited by the Following 4 Articles in this Archive:
Rapamycin versus Methotrexate in Early Diffuse Systemic Sclerosis: Results from a Randomized, Single-blind Pilot Study
Tien-I Karleen Su, Dinesh Khanna, Daniel E. Furst, Gabriel Danovitch, Christina Burger, Paul Maranian, Philip J. Clements
Arthritis Rheum. Author manuscript; available in PMC 2010 December 1.
Published in final edited form as: Arthritis Rheum. 2009 December; 60(12): 3821–3830. doi: 10.1002/art.24986
PMCID:
PMC2841149
Abstract Full Text PDF–315K Supplementary Material
Endothelin B Receptor, a New Target in Cancer Immune Therapy
Lana E. Kandalaft, Andrea Facciabene, Ron J. Buckanovich, George Coukos
Clin Cancer Res. Author manuscript; available in PMC 2010 July 5.
Published in final edited form as: Clin Cancer Res. 2009 July 15; 15(14): 4521–4528. Published online 2009 June 30. doi: 10.1158/1078-0432.CCR-08-0543
PMCID:
PMC2896814
Abstract Full Text PDF–785K
Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue disease
Lewis J Rubin, Carol M Black, Christopher P Denton, James R Seibold
Arthritis Res Ther. 2007; 9(Suppl 2): S10. Published online 2007 August 15. doi: 10.1186/ar2194
PMCID:
PMC2072884
Abstract Full Text PDF–43K
Systemic sclerosis and related connective tissue diseases: present and future
Lewis J Rubin, Carol M Black, Christopher P Denton, James R Seibold
Arthritis Res Ther. 2007; 9(Suppl 2): S1. Published online 2007 August 15. doi: 10.1186/ar2185
PMCID:
PMC2072885
Full Text PDF–32K
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk